Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Amylyx Pharmaceuticals (AMLX) Interest & Investment Income (2021 - 2025)

Historic Interest & Investment Income for Amylyx Pharmaceuticals (AMLX) over the last 5 years, with Q3 2025 value amounting to $1.8 million.

  • Amylyx Pharmaceuticals' Interest & Investment Income fell 4122.01% to $1.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $8.3 million, marking a year-over-year decrease of 4750.38%. This contributed to the annual value of $13.8 million for FY2024, which is 1452.18% down from last year.
  • Latest data reveals that Amylyx Pharmaceuticals reported Interest & Investment Income of $1.8 million as of Q3 2025, which was down 4122.01% from $2.0 million recorded in Q2 2025.
  • In the past 5 years, Amylyx Pharmaceuticals' Interest & Investment Income ranged from a high of $4.4 million in Q4 2023 and a low of $1000.0 during Q2 2021
  • Over the past 5 years, Amylyx Pharmaceuticals' median Interest & Investment Income value was $2.2 million (recorded in 2025), while the average stood at $2.1 million.
  • In the last 5 years, Amylyx Pharmaceuticals' Interest & Investment Income soared by 4010000.0% in 2022 and then crashed by 5183.09% in 2025.
  • Quarter analysis of 5 years shows Amylyx Pharmaceuticals' Interest & Investment Income stood at $30000.0 in 2021, then surged by 10423.33% to $3.2 million in 2022, then surged by 38.45% to $4.4 million in 2023, then tumbled by 47.01% to $2.3 million in 2024, then decreased by 21.37% to $1.8 million in 2025.
  • Its Interest & Investment Income was $1.8 million in Q3 2025, compared to $2.0 million in Q2 2025 and $2.2 million in Q1 2025.